According to the National Institute of Health, chronic kidney disease (CKD) is common in adults in the US, with more than 37 million American adults living with the disease1. In advanced stages, CKD can...
Well, here we are, two weeks into May (don’t blink or you might miss it!), and well into the UDS+ Calendar Year 2023 (CY23) voluntary submissions. In case you missed it, on March 26th Azara became the first vendor to successfully submit data to HRSA...
In Part One of the blog series, I shared stats and facts to help better understand colorectal cancer prevention and how to improve screening rates. Now let's explore some simple ways to use Azara DRVS to assist in engaging your patients for...
The United States has made significant strides in cancer treatment options, diagnostic tools, and prevention strategies to drive down cancer rates over the past two decades. Among cancer types, colorectal cancer is the third most common and second...
Have you ever watched your claims metrics change over time?Right before a big meeting you revisit some claim metrics—last week you calculated $100 dollars, but today you see $125.Why oh why?!Sometimes it seems like you are a cartoon cat chasing a...
